首页> 外文期刊>Clinical and experimental hypertension: CEH >Effects of a neutral endoprotease enzyme inhibitor, thiorphan, on hemodynamics and renal excretory function in four models of experimental hypertension.
【24h】

Effects of a neutral endoprotease enzyme inhibitor, thiorphan, on hemodynamics and renal excretory function in four models of experimental hypertension.

机译:在四种实验性高血压模型中,一种中性内切蛋白酶抑制剂thiorphan对血液动力学和肾脏排泄功能的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Thiorphan, a neutral endoprotease (NEP) enzyme inhibitor, has been shown to enhance the effects of atrial natriuretic peptide (ANP) in vivo. In this study, we examined the effects of an intravenous (iv) infusion of thiorphan on cardiovascular hemodynamics and excretion of urine volume (UV), sodium (U(Na)V) and potassium (UKV) in four different models of experimental hypertension, namely: 1) SHR, 2) two-kidney, one clip (2K1C),3) one-kidney, 1 clip (1K1C) and. 4) 70% reduced renal mass-salt (RRM-S) hypertensive rats. SHR has normal plasma renin activity, 2K1C is renin dependent, and 1K1C and RRM-S are low renin volume dependent models of hypertension. Rats were divided into experimental and control groups. Under inactin (120 mg/kg, body weight) anesthesia, rats were instrumented to record blood pressure and dP/dt (Millar catheter) and urine was collected through a suprapubic urinary bladder catheter. Experimental animals received an iv infusion of thiorphan, 0.5 mg/kg/min for 120 minutes. Control animals received vehicle only. In some animals, vascular smooth muscle cell membrane potentials (Em) was measured in vivo. In another series of experiments, using the identical protocol, cardiac output was recorded. The thiorphan infusion produced a similar progressive decrease in blood pressure in all models of hypertension. Cardiac output did not change relative to vehicle infused control animals. Thus pressure decreased because of a decrease in total peripheral resistance. The contractility index (dP/dt/P, where P = left ventricular pressure) did not change but vascular smooth muscle cells in tail arteries hyperpolarized in all four models. In spite of a significant decrease in blood pressure, thiorphan infusion either increased or produced no change in urinary volume (UV) and sodium (U(Na)V) excretion. These data show that thiorphan, an NEP inhibitor, decreases the blood pressure of hypertensive rats due to a decrease in total peripheral resistance, perhaps by hyperpolarizing vascular smooth muscle cells. These effects are independent of the mechanism of the hypertension. Increased UV and U(Na)V in the face of decreased pressure suggests a direct renal effect.
机译:噻吗啡,一种中性内切蛋白酶(NEP)酶抑制剂,已显示出在体内增强心钠素(ANP)的作用。在这项研究中,我们研究了在四种不同的实验性高血压模型中,静脉注射(iv)噻吨对心血管血液动力学和尿液(UV),钠(U(Na)V)和钾(UKV)排泄的影响,即:1)SHR,2)两肾,一个夹子(2K1C),3)一肾,一个夹子(1K1C)和。 4)降低了70%的肾脏重盐(RRM-S)高血压大鼠。 SHR具有正常的血浆肾素活性,2K1C是肾素依赖性的,1K1C和RRM-S是低肾素容量依赖性的高血压模型。将大鼠分为实验组和对照组。在inactin(120 mg / kg,体重)麻醉下,对大鼠进行记录血压和dP / dt(Millar导管)的仪器,并通过耻骨上膀胱导尿管收集尿液。实验动物接受静脉输注0.5 mg / kg / min的噻吨芬120分钟。对照动物仅接受媒介物。在一些动物中,在体内测量了血管平滑肌细胞膜电位(Em)。在另一系列实验中,使用相同的协议记录了心输出量。在所有高血压模型中,硫氧烷输注都会使血压逐渐降低。相对于载体注入的对照动物,心输出量没有变化。因此,由于总外围电阻的减小,压力减小了。在所有四个模型中,收缩指数(dP / dt / P,其中P =左心室压力)没有变化,但是尾动脉的血管平滑肌细胞超极化。尽管血压显着降低,但硫氧烷输注量增加或不改变尿量(UV)和钠(U(Na)V)排泄量。这些数据表明,由于总外周阻力的降低(可能是通过使血管平滑肌细胞超极化),一种NEP抑制剂噻吗啡降低了高血压大鼠的血压。这些作用与高血压的机制无关。面对压力降低,UV和U(Na)V升高表明有直接的肾脏作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号